Oral Abstract Session:
106. Pneumococcal Vaccine for All Ages
Friday, October 4, 2013: 10:30 AM-12:00 PM
Room: The Moscone Center: 200-212

Learning Objectives:


Target Audience: infectious diseases physicians

Topical Category: I. Adult and Pediatric Vaccines

Tracks: Pediatric ID, Adult ID

Moderator:  Ruth Lynfield, MD, Minnesota Department of Health


10:30 AM
Multicenter Surveillance of Streptococcus pneumoniae isolates from middle ear cultures in the 13-valent Pneumococcal Conjugate Vaccine Era
Sheldon L. Kaplan, MD, FIDSA ; William J. Barson, MD ; Philana L. Lin, MD, MSc ; Jose R. Romero, MD ; John S. Bradley, MD, FIDSA ; Tina Q. Tan, MD ; Timothy R. Peters, MD ; Jill A. Hoffman, MD ; Kristina G. Hulten, PhD ; Kimberly J. Center, MD ; Edward O. Mason, PhD

10:45 AM
An Investigation of Genes Encoding Potential Vaccine Targets Across Genetically Unrelated Pediatric Clinical Streptococcus pneumoniae Isolates in the Post Pneumococcal Conjugate Vaccine Era
Kristina G. Hulten, PhD ; Edward O. Mason, PhD ; Linda B. Lamberth, BS ; William J. Barson, MD ; Philana L. Lin, MD, MSc ; Jose R. Romero, MD ; John S. Bradley, MD, FIDSA ; Tina Q. Tan, MD ; Laurence B. Givner, MD ; Jill A. Hoffman, MD ; John M. Mclaughlin, PhD, MSPH ; Stephen Kagan, MD, FACP ; Sheldon L. Kaplan, MD, FIDSA

11:00 AM
Rates of Invasive Pneumococcal Disease among Persons with and without Immunocompromising Conditions in the Era of Pneumococcal Conjugate Vaccine Use — United States, 2007–09
Aaron Harris, MD, MPH ; Ryan Gierke, MPH ; Amanda Payne, MPH ; Ruth Link-Gelles, MPH ; Jessica King, MPH ; Mi Chen, MS ; William Schaffner, MD ; Susan Petit, MPH ; Ann Thomas, MD, MPH ; Nancy M. Bennett, MD ; Monica M. Farley, MD ; Ruth Lynfield, MD ; Deborah Aragon, MSPH ; Arthur Reingold, MD ; Lee Harrison, MD ; Megin Nichols, DVM, MPH, DACVPM ; Tamara Pilishvili, MPH ; Kathleen Dooling, MD, MPH

11:15 AM
Indirect Effects of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Pneumonia in Adults
Lindsay Kim, MD, MPH ; Ryan Gierke, MPH ; Melissa Lewis, MPH ; Ruth Link-Gelles, MPH ; Monica M. Farley, MD ; William Schaffner, MD ; Ann Thomas, MD, MPH ; Arthur Reingold, MD ; Lee Harrison, MD ; Ruth Lynfield, MD ; Nancy Bennett, MD, MS ; Susan Petit, MPH ; Lisa Miller, MD, MSPH ; Joseph Bareta, MS ; Lesley Mcgee, PhD ; Cynthia Whitney, MD, MPH ; Matthew Moore, MD, MPH

11:30 AM
Immunological efficacy of a Prime-Boost Strategy Combining a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by a 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Versus PPV23 Alone in HIV-Infected Adults
Corinna Sadlier, MD ; Niall Conlon, MD, PhD ; Clare Rock, MD ; Aisling Brown, MD ; Siobhan O'Dea ; Jean Dunne, PhD ; Con Feighery, MD, PhD ; Colm Bergin, MD, FRCPI

11:45 AM
Effectiveness of pneumococcal heptavalent conjugate vaccine for the prevention of community-acquired pneumonia using a 2+1 Infant Schedule in Québec, Canada
Jeannette Ndaya-Tshibangu ; Louis Valiquette, MD, MSc ; Philippe De Wals, MD, PHD ; Thomas Lemaitre, MSc ; Genevieve Petit, MD, MSc ; Jean Paul Praud, MD, MSc ; Genevieve Deceuninck, MD, MSc ; Arnaud Gagneur, MD, PhD

CME Credits:

ACPE Credits:

ACPE Number:

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.